SCHEMBL4950283

SCHEMBL4950283

CC(C=O)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7495380 0.80
SCHEMBL10583161 0.79 ALOX5 (0.42)
SCHEMBL9729168 0.78
SCHEMBL467496 0.75
SCHEMBL1696175 0.74
SCHEMBL21495020 0.74
SCHEMBL6731353 0.74
SCHEMBL22774795 0.74
SCHEMBL5750352 0.74
SCHEMBL1696274 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101870700-B Method for synthesizing Indiplon UNIV PLA 3RD MILITARY MEDICAL 2012-05-23 CN claimed
CN-101870700-A Method for synthesizing Indiplon UNIV PLA 3RD MILITARY MEDICAL 2010-10-27 CN claimed
CN-109422765-A C class beta-lactamase inhibitor and its preparation method and application 香港理工大学深圳研究院 2019-03-05 CN disclosed
CN-105164125-B 2-phenyl or 2-heteroaryl imidazo [1,2-a ] pyridine derivatives 豪夫迈·罗氏有限公司 2017-10-13 CN disclosed
JP-2013256501-A (E)-N-MONOALKYL-3-OXO-3-(2-THIENYL)PROPENAMINE AND METHOD FOR MANUFACTURING THE SAME AS WELL AS METHOD FOR MANUFACTURING (E, Z)-N-MONOALKYL-3-OXO-3-(2-THIENYL) PROPENAMINE SUMITOMO SEIKA CHEM CO LTD 2013-12-26 JP disclosed
JP-5361187-B2 2013-12-04 JP disclosed
CN-101535260-B Thiophene compounds NAT HEALTH RESEARCH INSTITUTES 2012-07-04 CN disclosed
CN-101870700-B Method for synthesizing Indiplon UNIV PLA 3RD MILITARY MEDICAL 2012-05-23 CN disclosed
CN-101870700-A Method for synthesizing Indiplon UNIV PLA 3RD MILITARY MEDICAL 2010-10-27 CN disclosed
CN-101535260-A Thiophene compounds NAT HEALTH RESEARCH INSTITUTES (CN) 2009-09-16 CN disclosed
US-7365085-B2 Compounds and methods SMITHKLINE BEECHAM CORPORATION (US) 2008-04-29 US disclosed
EP-1575495-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2005-09-21 EP disclosed
US-20050113580-A1 Amide compounds and methods of using the same SMITHKLINE BEECHAM CORP 2005-05-26 US disclosed
WO-2003082205-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-09 WO disclosed
CN-1329648-A Material consisting of cyanoacrylate and aldehyde-or ketone-condensation products for adhesives, coatings and sealants HENKEL KGAA (DE) 2002-01-02 CN disclosed
CN-1252070-A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors ABBOTT LAB (US) 2000-05-03 CN disclosed
EP-0274434-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-07-13 EP disclosed
US-4749717-A 1-(2- OR 3-THIENYLALKYL)IMIDAZOLE-2-THIOLS AND 1-(2- OR 3-THIENYLALKYL)-2-ALKLYTHIOMIDAZOLES; HYPOTENSIVE AGENT, DIURETIC SMITHKLINE BECKMAN CORPORATION (US) 1988-06-07 US disclosed
EP-0244195-A1 2-Vinylpenams and process THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (GB) 1987-11-04 EP disclosed
US-4087549-A Sulphonic acid containing indenyl derivatives MERCK & CO., INC. (US) 1978-05-02 US disclosed